Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study

This publication has 42 references indexed in Scilit:

• Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Cervical Cancer Patients Treated With Chemoradiotherapy
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
• Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study
  BMC Cancer, 2011
• Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
  New England Journal of Medicine, 2010
• Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy
  Gynecologic Oncology, 2007
• Progress in the Management of Gynecologic Cancer: Consensus Summary Statement
  Journal of Clinical Oncology, 2003
• Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  JNCI: Journal of the National Cancer Institute, 2000
• Consolidation Radiotherapy after Carboplatin-Based Chemotherapy in Radically Operated Advanced Ovarian Cancer
  Gynecologic Oncology, 1999
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Outcome of patients with unfavorable optimally cytoreduced ovarian cancer treated with chemotherapy and whole abdominal radiation
  Gynecologic Oncology, 1991
• Optimal two-stage designs for phase II clinical trials
  Controlled Clinical Trials, 1989